These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 20698311)

  • 41. [The relation between Chlamydia pneumoniae infection and abdominal aortic aneurysm].
    Wolski A; Mazur E; Niedźwiadek J; Slepko J; Kozioł-Montewka M; Michalak J
    Pol Merkur Lekarski; 2001 Dec; 11(66):491-4. PubMed ID: 11899845
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Chlamydia pneumoniae and coronary artery disease: legitimized linkages?
    Higgins JP; Higgins JA; Higgins PM; Ahuja S; Higgins DL
    Expert Rev Cardiovasc Ther; 2003 Sep; 1(3):367-84. PubMed ID: 15030265
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Effect of Chlamydia pneumoniae infection on coronary flow reserve and intimal hyperplasia after stent implantation in patients with angina pectoris.
    Tanaka T; Matsushita M; Oka Y; Sada T; Kira Y
    J Cardiol; 2001 Dec; 38(6):311-7. PubMed ID: 11806088
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The adventitia of atherosclerotic coronary arteries frequently contains Chlamydia pneumoniae.
    Vink A; Pasterkamp G; Poppen M; Schoneveld AH; de Kleijn DP; Roholl PJ; Fontijn J; Plomp S; Borst C
    Atherosclerosis; 2001 Jul; 157(1):117-22. PubMed ID: 11427210
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Morphometrical quantification of Chlamydia pneumoniae and Mycoplasma pneumoniae in human atherosclerotic abdominal aortic aneurysms.
    Pires LJ; Gutierrez PS
    Rev Bras Cir Cardiovasc; 2007; 22(3):322-31. PubMed ID: 18157418
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Chlamydia pneumoniae in an ex vivo human artery culture model.
    Poppert S; Schlaupitz K; Marre R; Voisard R; Roessler W; Weckermann D; Weingärtner K; Essig A
    Atherosclerosis; 2006 Jul; 187(1):50-6. PubMed ID: 16202418
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Quantification and location of Chlamydia pneumoniae-specific antigen in the walls of abdominal aortic aneurysms.
    Xiong F; Zhao JC
    Ann Vasc Surg; 2011 Feb; 25(2):256-63. PubMed ID: 21315234
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Markers of Chlamydia pneumoniae and human cytomegalovirus infection in patients with chronic peripheral vascular disease and their relation to inflammation, endothelial dysfunction and changes in lipid metabolism.
    Kraml PJ; Roubalová K; Bulvas M; Sommerová Z; PotoCková J; Mandys V; Andel M
    Folia Microbiol (Praha); 2008; 53(6):551-7. PubMed ID: 19381484
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Chlamydia Pneumoniae and Immunoinflammatory Reactions in an Unstable Atherosclerotic Plaque in Humans.
    Pigarevskii PV; Mal'tseva SV; Snegova VA; Davydova NG; Guseva VA
    Bull Exp Biol Med; 2015 Jun; 159(2):278-81. PubMed ID: 26085364
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Mycoplasma pneumoniae and/or Chlamydophila pneumoniae inoculation causing different aggravations in cholesterol-induced atherosclerosis in apoE KO male mice.
    Damy SB; Higuchi ML; Timenetsky J; Reis MM; Palomino SP; Ikegami RN; Santos FP; Osaka JT; Figueiredo LP
    BMC Microbiol; 2009 Sep; 9():194. PubMed ID: 19744321
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [A method for preparation of an endothelial cell monolayer sample from the blood vessel intima].
    Solovyeva NA
    Arkh Patol; 2018; 80(5):51-53. PubMed ID: 30335061
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Chlamydia pneumoniae and chronic skin wounds: a focused review.
    King LE; Stratton CW; Mitchell WM
    J Investig Dermatol Symp Proc; 2001 Dec; 6(3):233-7. PubMed ID: 11924834
    [TBL] [Abstract][Full Text] [Related]  

  • 53. A review: Pathological and molecular biological study on atherosclerosis.
    Jing L; Shu-Xu D; Yong-Xin R
    Clin Chim Acta; 2022 Jun; 531():217-222. PubMed ID: 35429487
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Chlamydophila pneumoniae infection and cardiovascular disease.
    Joshi R; Khandelwal B; Joshi D; Gupta OP
    N Am J Med Sci; 2013 Mar; 5(3):169-81. PubMed ID: 23626952
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Chlamydophila pneumoniae derived from inclusions late in the infectious cycle induce aponecrosis in human aortic endothelial cells.
    Marino J; Stoeckli I; Walch M; Latinovic-Golic S; Sundstroem H; Groscurth P; Ziegler U; Dumrese C
    BMC Microbiol; 2008 Feb; 8():32. PubMed ID: 18284660
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Analysis of the heterogenicity of cytological and morphometric indices of the endothelial nuclei of the aorta and pulmonary artery in atherosclerosis].
    Solov'eva NA; Lysenko LV; Lysenko AI
    Arkh Patol; 2008; 70(3):37-41. PubMed ID: 18727432
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Chlamydia pneumoniae infection of endothelial cells induces transcriptional activation of platelet-derived growth factor-B: a potential link to intimal thickening in a rabbit model of atherosclerosis.
    Coombes BK; Chiu B; Fong IW; Mahony JB
    J Infect Dis; 2002 Jun; 185(11):1621-30. PubMed ID: 12023768
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Chlamydia pneumoniae-induced pathological signaling in the vasculature.
    Kern JM; Maass V; Maass M
    FEMS Immunol Med Microbiol; 2009 Mar; 55(2):131-9. PubMed ID: 19281565
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [The implication of Chlamydia pneumoniae in damage to human aortic endotheliocytes in atherosclerosis].
    Lysenko AI; Solov'eva NA
    Arkh Patol; 2010; 72(2):21-5. PubMed ID: 20698311
    [TBL] [Abstract][Full Text] [Related]  

  • 60.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.